Unihealth Hospitals Q4 FY26 Share Price & Earnings Call Analysis
- Market cap
- ₹875 Cr
- P/E
- 34.11
- ROE
- 21.46%
- PEG
- 0.69
- Price to sales
- 6.63
- Debt to equity
- 0.24
- 52W high / low
- ₹807 / ₹155
- Sales growth (5Y)
- 38.17%
- EBITDA margin
- 40.76%
- Net profit margin
- 34.39%
- Promoter holding
- 64.82%
- Sales (last year)
- ₹132 Cr
Incorporated in 2010, Unihealth Consultancy Ltd is in the business of Medical Tour Operator and Health Consultancy Service & Trader in Medical Equipments[1]
Guidance scorecard · Q4 FY26 call
What Unihealth Hosp's management guided
and where it ranks in Healthcare Services
RevenueQ2 FY26 call
20–40%- UniHealth plans a significant multi-pronged expansion over 5-7 years, targeting greenfield projects, acquisitions, and operational management outsourcing.
- FY 27-28 target: achieve 1,000 beds.
- Revenue contribution from Uganda is currently 90%, expected to drop to 50-60% by end of FY 27-28, with India contributing 40-50%; Tanzania to add revenue in coming years.
- Navi Mumbai and Nashik hospitals (India) expected to contribute ~INR125 crore revenue next financial year.
- Navi Mumbai (52 beds) aims for 60-70% occupancy in FY 27; Nashik (200 beds) to reach ~50% occupancy by Q2 FY 28.
- Average revenue per occupied bed in India expected to scale from INR27,000-28,000 to INR55,000-60,000 over 3-5 years.
2 more points from Unihealth Hosp's call on revenue
Create a free account to keep reading this call
MarginsQ2 FY26 call
Down 0–2%See what Unihealth Hosp said on margins — free account, 30 seconds.
CapexQ2 FY26 call
Planned- Navi Mumbai capex completed using IPO proceeds from 2023.
- Nashik financial closure achieved via equity and bank debt (INR 22 crores from Bank of India).
- 20-bedded secondary care center in Tanzania achieved financial closure with internal equity approvals.
- Planned 100-bedded tertiary care hospital in Tanzania under final discussion; funding needed.
- Pune has a multi-pronged expansion plan including greenfield projects, operational acquisitions, or O&M models.
- Target to achieve 1,000 operational beds across India and Africa by FY 2027-28.
- Future projects like Pune and the 100-bed Tanzania facility will require a mix of internal accruals, bank debt, and possibly capital leasing.
2 more points from Unihealth Hosp's call on capex
Create a free account to keep reading this call
FundraisingQ2 FY26 call
PlannedSee what Unihealth Hosp said on fundraising — free account, 30 seconds.
Order bookQ2 FY26 call
- Currently, UniHealth Hospitals is handling about 1,300 beds on a consolidated basis in consultancy projects, which has been stable over the last 12+ months.
- They have completed some smaller consultancy projects recently and added a couple of new ones.
- There are ongoing discussions for consultancy projects involving an additional 600-650 beds in total.
- These discussions are in initial stages, pending financial closure by the investors before formal agreements.
- UniHealth is a shortlisted consultant for these projects, but no formal contracts have yet been signed.
- Project cycles from initial consultancy to completion typically take 2 to 5 years.
2 more points from Unihealth Hosp's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Healthcare Services companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹921 Cr | — | |
| 2 | 40%+ | Flat | ₹575 Cr | 21.9 | |
| 3 | Aster DM Quality Care Ltd | 20–40% | Up 2%+ | ₹59,405 Cr | 164.6 |
| 4 | 20–40% | Up 2%+ | ₹551 Cr | 18.5 | |
| 5 | 20–40% | Up 0–2% | ₹1,635 Cr | 16.5 | |
| 6 | 20–40% | Flat | ₹1.21L Cr | 57.7 |
Sign up free to see every company in the sector ranking and track Unihealth Hosp.
Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services rankingFinancials of Unihealth Hosp
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Unihealth Hosp
Quarterly Results
Quarter-by-quarter operating performance
Financials of Unihealth Hosp
Profit & Loss
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales + | 22 | 26 | 37 | 44 | 49 | 56 | 122 |
| Expenses + | 20 | 20 | 25 | 30 | 31 | 37 | 69 |
| Operating Profit | 2 | 7 | 12 | 14 | 18 | 18 | 53 |
| OPM % | 10% | 25% | 31% | 31% | 36% | 33% | 43% |
| Other Income + | 1 | 2 | 1 | 2 | 2 | 3 | 4 |
| Interest | 2 | 1 | 5 | 4 | 3 | 2 | 2 |
| Depreciation | 2 | 2 | 2 | 3 | 2 | 2 | 8 |
| Profit before tax | -1 | 5 | 5 | 9 | 14 | 17 | 47 |
| Tax % | 2% | 9% | 27% | 17% | 24% | 12% | |
| Net Profit + | -1 | 5 | 4 | 8 | 10 | 15 | 47 |
| EPS in Rs | |||||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Unihealth Hosp
Balance Sheet
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 1 | 15 | 15 | 16 |
| Reserves | 4 | 9 | 13 | 26 | 70 | 88 | 110 |
| Borrowings + | 41 | 39 | 38 | 39 | 15 | 13 | 18 |
| Other Liabilities + | 12 | 9 | 12 | 12 | 10 | 15 | 78 |
| Total Liabilities | 58 | 58 | 65 | 78 | 110 | 132 | 221 |
| Fixed Assets + | 35 | 35 | 36 | 37 | 36 | 40 | 72 |
| CWIP | 2 | 0 | 0 | 0 | 0 | 5 | 10 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 20 | 22 | 28 | 41 | 74 | 87 | 139 |
| Total Assets | 58 | 58 | 65 | 78 | 110 | 132 | 221 |
Financials of Unihealth Hosp
Cash Flows
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 1 | 4 | 9 | 1 | 5 | -3 |
| Cash from Investing Activity + | -1 | 0 | -3 | -5 | 0 | -8 |
| Cash from Financing Activity + | 1 | -3 | -6 | 3 | 21 | -3 |
| Net Cash Flow | 0 | 1 | 0 | -0 | 27 | -14 |
| Free Cash Flow | -1 | 4 | 8 | -1 | 2 | -13 |
| CFO/OP | 32% | 62% | 81% | 22% | 41% | -6% |
Financials of Unihealth Hosp
Ratios
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 206 | 198 | 180 | 228 | 251 | 328 |
| Inventory Days | 50 | 86 | 78 | 98 | 88 | 64 |
| Days Payable | 382 | 91 | 79 | 137 | 104 | 86 |
| Cash Conversion Cycle | -125 | 192 | 180 | 188 | 235 | 306 |
| Working Capital Days | 24 | 137 | 126 | 141 | 203 | 270 |
| ROCE % | 14% | 20% | 22% | 20% | 17% |
Guidance history
How Unihealth Hosp's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q2 FY26 call → | 20–40% | Down 0–2% | Planned | Planned | — |
| Q4 FY25 call → | 20–40% | Flat | Planned | Planned | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
34 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | +227.0% | 99% |
| Last 6 months | +13.8% | 71% |
| Last 3 months | −32.0% | 3% |
The price is 32% below its all-time high of ₹807.35 (3 Aug 2026). Stocks more than 20% below their peak have their score halved, so 69 became 34.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Unihealth Hosp: 0.4 × 99 + 0.4 × 71 + 0.2 × 3 = 69, halved to 34 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Unihealth Hosp's management said in earlier quarters
Others in Healthcare Services this season
- Vijaya Diagnostic Centre (Q2 FY27)
Q2 FY27 Revenue from Operations: INR 2,554 Mn, up 26.7% YoY (Page 10, 9) . Key investor presentation takeaways from Vijaya Diagnostic Centre Ltd's Q2 FY27 inves
- Shalby (Q2 FY27)
Consolidated Total Revenue for Q2 FY27: ₹3,182 million vs ₹2,899 million in Q2 FY26, up 9.8% YoY (Pages 5, 6, 8, 9) . Key investor presentation takeaways from S
- Metropolis Healt (Q2 FY27)
Q2FY27 revenue from operations: INR 496.8 Cr, up 15.8% YoY (Page 11) . Key investor presentation takeaways from Metropolis Healthcare Ltd's Q2 FY27 investor pre
- Nephrocare Health Services (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹303.4 Cr, up 23.5% YoY from ₹245.7 Cr in Q2 FY26 (Page 9). Key investor presentation takeaways from Nephrocare Health Services